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Abstract: Matrix metalloproteinases (MMP) 2 and 9, the gelatinases, have consistently 
been associated with tumor progression. The development of gelatinase-specific probes 
will be critical for identifying in vivo gelatinoic activity to understand the molecular role of the 
gelatinases in tumor development. Recently, a self-assembling homotrimeric triple-helical 
peptide (THP), incorporating a sequence from type V collagen, with high substrate 
specificity to the gelatinases has been developed. To determine whether this THP would be 
suitable for imaging protease activity, 5-carboxyfluorescein (5FAM) was conjugated, 
resulting in 5FAM3-THP and 5FAM6-THP, which were quenched up to 50%. 5FAM6-THP 
hydrolysis by MMP-2 and MMP-9 displayed kcat/KM values of 1.5 × 104 and 5.4 × 103 M−1 s−1, 
respectively. Additionally 5FAM6-THP visualized gelatinase activity in gelatinase positive 
HT-1080 cells, but not in gelatinase negative MCF-7 cells. Furthermore, the fluorescence 
in the HT-1080 cells was greatly attenuated by the addition of a MMP-2 and MMP-9 
inhibitor, SB-3CT, indicating that the observed fluorescence release was mediated by 
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gelatinase proteolysis and not non-specific proteolysis of the THPs. These results 
demonstrate that THPs fully substituted with fluorophores maintain their substrate 
specificity to the gelatinases in human cancer cells and may be useful in in vivo molecular 
imaging of gelatinase activity.  
Keywords: matrix metalloproteinase-2 (MMP-2); MMP-9; gelatinase; triple-helical 
peptides; optical imaging; fluorescence molecular tomography (FMT) 
 
1. Introduction 
Matrix metalloproteinases (MMPs) are a family of zinc dependent endopeptidases that are capable 
of degrading extracellular matrix (ECM) components such as collagen, elastin, gelatin, and 
proteoglycans. The MMPs can be classified into different groups. One such group is the gelatinases, 
which consists of the type IV collagenases MMP-2 and MMP-9. Normally, MMP levels are low; 
however, they are elevated during cell proliferation, cell migration, and tissue remodeling events [1]. 
MMPs are initially synthesized as inactive zymogens (pro-MMP) and are secreted into the 
extracellular space, anchored to the cell membrane, or remain localized inside of the cells [2,3]. Upon 
cleavage of the pro-peptide domain, the active site is exposed within the catalytic domain [4].  
MMPs may also be activated under oxidative stress by the combined action of peroxynitrite and 
glutathione [5]. MMPs, including the gelatinases have been implicated in various disease processes, 
such as cancer. MMP-2 and MMP-9 activity is upregulated in breast [6,7], colorectal [8,9],  
prostate [10,11], and gastric cancers [12,13], fueling the development and metastatic processes of these 
tumors through degradation of ECM, regulation of angiogenesis, stromal invasion [14], and 
extravasation at the metastatic site [15]. 
Molecular optical imaging has become of great interest recently for its use in non-invasive 
diagnostics and intraoperative fluorescence-guided surgery [16–19]. The development of optical 
imaging probes capable of detecting gelatinase activity would be useful in these in vivo applications 
since gelatinase activity has good prognostic capability. For instance, MMP-2 and -9 activity have 
been hypothesized to be involved in metastatic events and predict patient outcome in breast [20–22], 
prostate [23,24], and colorectal cancers [8,9]. 
Previously, our group and others have synthesized peptide substrates for detecting gelatinase 
activity [25–30]. To our knowledge, our triple-helical peptide (THP) has shown some of the best 
specificity for the gelatinases over other MMP family members. Selectivity towards the gelatinases is 
of high significance since other MMP family members, such as MMP-1, MMP-3, MMP-13, and 
MMP-14 are often expressed by the cancer cells of the primary tumor, surrounding stromal cells, and 
endothelial cells [18]. This THP is a self-assembling homotrimeric THP that includes the native 
collagen type V sequence, GPPG~VVGEKGEQ (the scissile bond lies between G and V), in the 
single-stranded peptides. Inclusion of repeating Gly-Pro-4-hydroxy-L-proline (GPO) triplets at both 
the N- and C-termini allow for the self-assembly of three single-stranded peptides into a single THP, 
imparting specificity for cleavage by the gelatinases in addition to the native collagen sequence [31]. While 
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this peptide did not discriminate between the gelatinases, this is not a serious shortcoming since the 
gelatinases are secreted and activated simultaneously [32,33]. 
After the success of our previous studies, we continue to further evaluate the potential of  
triple-helical peptides for proteolytic imaging [34]. The goal of this study was to determine whether 
single-stranded peptides bearing 5-carboxyfluorescein (5FAM) dyes would assemble into a triple-helix 
and function as a substrate for gelatinases with kinetic parameters suitable for the in vivo detection of 
gelatinase activity. 5FAM was chosen due to its commercial availability, amenability to solid phase 
peptide synthesis, high quantum yield, and the ubiquity of fluorescein filter sets in a variety of 
fluorescence imaging equipment [35]. Moreover, the choice of a single dye for homo-quenching 
simplifies the synthesis of the probe. The on-resin conjugation procedure of 5FAM to single-stranded 
peptides was modified to increase conjugation efficiency. The resulting triple-helical peptides  
(5FAM-THPs) bear fluorophores conjugated to ε-amino Lys groups that flank the hydrolysis site. The 
kinetic parameters and structural properties of 5FAM-THPs were evaluated, as well as whether  
5FAM-THPs bearing homodimeric dyes would visualize gelatinase activity secreted by human cancer 
cells with confocal fluorescence microscopy. 
2. Results and Discussion 
2.1. 5FAM-THP Design and Synthesis 
Single-stranded collagen peptides were synthesized via solid phase peptide synthesis with a pair of 
Lys residues flanking the hydrolysis site to provide ε-amino groups for conjugation of either one or 
two 5FAM fluorescent dyes per single-stranded peptide (Figure 1). After cleavage from resin, three 
single-stranded collagen peptides labeled with 5-carboxyfluorescein (5FAM) self-assembled into the 
THPs, 5FAM3-THP and 5FAM6-THP. Mass spectrometric analysis of the purified 5FAM-THPs 
indicated mono- or di-substituted single-stranded peptides for 5FAM3-THP and 5FAM6-THP, 
respectively: 5FAM3-THP: calculated (M+H)+ = 4,463, observed (M+H)2+ = 2,233, (M+H)3+ = 1,489, 
(M+H)4+ = 1,117; 5FAM6-THP: calculated (M+H)+ = 4,819, observed (M+H)+ = 4,823, (M+2Na)+ = 4,845. 
Figure 1. (A) Solid phase synthesis of 5FAM3-THP and 5FAM6-THP (“O” represents  
4-hydroxyproline). The tilde represents the site of hydrolysis by gelatinases (B)  
5-carboxyfluorescein (5FAM).  
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The design of 5FAM-THP was based on the previous design of a fluorogenic THP substrate that 
fluoresced in the visible region (fTHP). The mechanism of quenching for fTHP was between  
7-methoxycoumarin and 2,4-dinitrophenyl groups which were conjugated to the ε-amino groups of  
Lys [29]. For synthetic ease, here we have chosen the fluorescein analogue 5FAM to serve as the 
fluorescent dye to report gelatinase activity since it is readily available from a variety of commercial 
sources, exhibits a high quantum yield, and is highly amenable to solid-phase peptide synthesis. A 
previously reported method, which detailed optimized coupling conditions with DIC, HOBt, and 
5FAM to achieve complete coupling of 5FAM to the N-terminal amino group, did not yield complete 
coupling with our single-stranded collagen peptide [35]. The addition of 4-dimethylaminopyridine 
(DMAP) was necessary to result in complete coupling of 5FAM to the Lys ε-amino groups, which was 
confirmed by both a ninhydrin test and ESI-TOF mass spectrometry. Previous work has shown that 
during coupling of activated 5FAM to resin bound peptides, more than one 5FAM molecule was 
conjugated via ester formation between the carboxylic acid and the phenolic oxygen of 5FAM [35]. 
Treatment with piperidine was required to remove these adducts. Here, DMAP may function as a 
nucleophile to remove the undesired esters during coupling of the 5FAMs. Alternatively, DMAP may 
act as an acyl transfer-reagent and facilitate the reaction between the Lys ε-amino groups and 5FAM 
carboxy groups, making the unwanted attack of the 5FAM phenolic oxygen that resulted in ester bond 
formation less favored [36,37]. When DMAP was not present in the coupling cocktail, the amide bond 
formation was too slow (Lys ε-amino groups are not as reactive as the N-terminal amino groups) and 
the side-reaction (esterification) occurred. This confirmed a new approach to coupling 5FAM to resin 
bound peptides with high coupling efficiency and obviated the need for an extra treatment with the 
nucleophilic base piperidine. 
2.2. 5FAM-THP Quenching 
A fully substituted 5FAM-THP was desired in anticipation of maximized self-quenching of the 
fluorophores upon THP self-assembly. The Kaiser test showed the completed substitution of 5FAM on 
the ε-amino groups of Lys of both conjugates while the peptide was resin bound and verified a 
substitution level of three 5FAM: one THP for 5FAM3-THP and six 5FAM: one THP for  
5FAM6-THP. By comparing the fluorescence of a fully proteolyzed sample of 5FAM-THP with an 
undigested sample, an average value of quenching of 32% ± 0.5% for 5FAM3-THP and 50% ± 2% for 
5FAM6-THP of 5FAM fluorescence was observed in the THPs. The fluorescence emission spectra of 
the 5FAM-THPs showed a slight shift to the red relative to unconjugated 5FAM with no other 
perturbations, except a decrease in fluorescence, which was due to the close proximity of the 
fluorophores (Figure 2). We previously showed that for a THP substituted with 1.8 5FAM per six 
available ε-amino groups, there was 38% quenching [34]. In this study, similar quenching levels were 
observed with 5FAM3-THP. However, complete substitution of the ε-amino groups in the  
5FAM6-THP conjugate resulted in 50% quenching of the fluorophores, which translated to a 2-fold 
increase in fluorescence after complete proteolysis.  
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Figure 2. Fluorescence emission spectra of 5FAM (solid) and 5FAM6-THP (dashed), 
where λexcitation = 480 nm. The decrease in fluorescence signal for 5FAM6-THP 
demonstrates the quenching of fluorescence of the fluorogenic peptide due to close 
proximity of the 5FAM fluorophores.  
 
To calculate the homo-FRET efficiency, the distance between the α-carbons of the lysines that are 
nine residues apart, which approximates the distance between dye-conjugated lysines that flank the 
hydrolysis site, were measured from a model of a THP [38]. Additional measurements were made 
between the α-carbons of inter-chain Lys residues. These distances ranged from 26 to 32 Å. Utilizing 
an average distance between α-carbons (R = 30 Å,), a Forster distance was estimated (R0 = 44 Å). 
Thus, the homo-FRET efficiency, when the fluorophores are separated by distance of 26 to 32 Å, 
ranges from 63% to 58%. These efficiencies are in good agreement with the measured level of 
quenching which was 50%. The level of quenching was related to the number of 5FAM substitutions, 
which might suggest that a FRET mechanism in the same peptide chain played an important role here. 
In contrast, previous work with more flexible single-stranded peptides, such as the MMP-7 substrate 
GVPLSLTMGC bearing a heterologous donor and acceptor pair of near infrared dyes on the N- and C- 
termini, yielded a level of 85% quenching with an approximate 7-fold increase in fluorescence after 
digestion with MMP-7 [39]. In flexible peptides, the mechanism of quenching has been attributed to 
the formation of intramolecular dimers between the donor and quencher fluorophores [40]. The triple-
helical conformation appears to be too rigid to permit extensive intramolecular association of the 
5FAM fluorophores and this may have limited the extent of quenching. Further, this level of quenching 
for 5FAM-THPs was lower than that observed with other fluorogenic probes that have been used in 
vivo, where the level of quenching has varied from 88% to 96% [30,33,41]. While the level of 
quenching of our 5FAM-THPs is sufficient for in vitro work, a higher level of quenching will most 
likely be desired for in vivo studies; however, it is important to note that in vivo imaging of proteolytic 
activity is in a nascent stage and values for minimum amounts of quenching have not yet been established.  
2.3. 5FAM-THP Kinetics 
In addition to achieving a high level of quenching, a fluorogenic peptide should be efficiently 
hydrolyzed by the enzyme. 5FAM-THPs were efficiently hydrolyzed by MMP-2 and MMP-9, 
indicating that the addition of the fluorophores did not perturb the triple-helical structure or change the 
substrate avidity of the THPs for the gelatinases (Table 1, Figure 3). The kcat/KM values for  
human-MMP-2 hydrolysis of 5FAM3-THP and 5FAM6-THP were 1.1 × 104 and 1.5 × 104 M−1 s−1, 
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respectively while the kcat/KM values for human-MMP-9 hydrolysis of 5FAM3-THP and 5FAM6-THP 
were 4.6 × 103 and 5.4 × 103 M−1 s−1, respectively, with similar values reported for hydrolysis of the 
5FAM-THPs with rat-MMP-2 and -9.  
Table 1. Enzyme kinetic parameters for gelatinase mediated hydrolysis of 5FAM-THPs. 
Substrate KM (μM) kcat (s−1) kcat/KM (M−1 s−1) MMPs 
fTHP a 4.4 0.061 14,002 MMP-2 
fTHP a 8.1 0.044 5,400 MMP-9 
5FAM3-THP 8.9 ± 0.7 b 0.092 10,337 MMP-2 
5FAM3-THP 10.2 ± 0.4 b 0.047 4,628 MMP-9 
5FAM3-THP 3.3 ± 0.3 b 0.051 15,421 MMP-2 (Rat) 
5FAM3-THP 8.9 ± 3.3 b 0.040 4,507 MMP-9 (Rat) 
5FAM6-THP 4.3 ± 0.3 b 0.065 15,116 MMP-2 
5FAM6-THP 6.6 ± 0.2 b 0.036 5,400 MMP-9 
a fTHP sequence is (GPhP)5GPK(Mca)GPPG~VVGEK(Dnp)GEN(GPhP)5-NH2, where Mca is  
(7-methoxycoumarin-4-yl)acetyl and Dnp is 2,4-dinitrophenyl; b error values are ± standard error of the  
mean (n = 3). 
Figure 3. Representative Lineweaver-Burk analysis of MMP-2 and MMP-9 mediated 
proteolysis of 5FAM6-THP. Enzyme kinetics were conducted by incubating activated 
MMP-2 or -9 enzyme with varying concentrations (1-100 µM) of THP substrate. Initial 
velocities were obtained from plots of fluorescence with respect to time using only the 
linear portion of the data. Relative fluorescence units were converted from known 
concentrations of 5FAM in assay buffer. KM values were determined by non-linear 
regression and fit with GraphPad Prism. Error bars are contained within the symbols.  
 
Other examples of protease imaging probes suggest that there is a range of kcat/KM values of  
~1 × 104 to 7 × 106 M−1 s−1 for proteolytic substrates that successfully imaged in vivo proteolytic 
activity [32,42,43]. The kcat/KM value for 5FAM-THP hydrolysis by MMP-2 falls inside this range, 
suggesting that THPs bearing quenched homodimeric dyes would be effective for gelatinase imaging 
in vivo providing that ample quenching is achieved. Since the KM and kcat values between the THPs 
were similar, the addition of the relatively bulky 5FAM fluorophores did not have a great effect on the 
5FAM-THP’s substrate avidity for the gelatinases (Table 1). Moreover, the circular dichroism spectra 
were strongly indicative of the triple-helical conformation for both 5FAM3-THP and 5FAM6-THP 
(Figure 4) [29,44]. More specifically, the maximum [Θ] value at λ ~222–225 nm and the minimum [Θ] 
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value at λ ~190 nm (Figure 4) are hallmarks of triple-helical structure, as is a sigmoidal melting curve 
when examining [Θ] = 225 nm as a function of increasing temperature (Figure 5). The kcat/KM value of 
a substrate is an important criterion as it provides a benchmark for the evaluation of a quenched 
substrate’s applicability for in vivo molecular imaging. Those substrates with the highest values would 
be expected to be the most rapidly hydrolyzed before wash-out from the target site, resulting in greater 
signal-to-noise. 5FAM6-THP was chosen to continue with further studies due to its higher level of 
quenching compared to conjugate 5FAM3-THP. 
Figure 4. Circular dichroism spectra of 5FAM6-THP (3.45 µM, 0.1% aqueous acetic acid). 
Spectra were collected over λ = 190–300 nm at 10 °C.  
 
Figure 5. Thermal transition curves for 5FAM6-THP determined by monitoring molar 
ellipticity (Θ = 225 nm) while the temperature was increased.  
 
2.4. Microscopy of 5FAM-THP Hydrolysis and MMP Zymography 
Selective proteolysis of 5FAM-THPs by gelatinases is necessary for in vivo applications. Confocal 
fluorescence microscopy of cells incubated with 5FAM6-THP verified that 5FAM-THPs were capable 
of visualizing gelatinase activity in gelatinase positive HT-1080 human fibrosarcoma cells relative to 
gelatinase negative MCF-7 human breast adenocarcinoma cells, without non-specific fluorescence due 
to denaturation or non-gelatinoic proteolysis (Figure 6A). When 5FAM6-THP was incubated with  
HT-1080 cells, which secrete 72 kDa-MMP-2 and 94 kDa-MMP-9 in culture [33,45], intracellular 
fluorescence was observed, which appeared to be vesicularly concentrated in some cases, which is 
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indicative of proteolysis by the gelatinases. In contrast when 5FAM6-THP was incubated with MCF-7 
cells, which do not secrete 72 kDa-MMP-2 or 94 kDa-MMP-9 [46], low levels of fluorescence were 
observed and there was no internalization of fluorescence (Figure 6A). Addition of the gelatinase 
inhibitor SB-3CT greatly reduced fluorescence levels when 5FAM6-THP was incubated with HT-1080 
cells by three-fold (Figure 6). This indicated that the observed fluorescence was due to gelatinase 
specific proteolysis of 5FAM6-THP and not due to proteolysis from other enzymes or other  
non-gelatinase specific processes (Figure 6A; the images shown are the center plane of the cells). 
Viability tests confirmed that cells used in the study were viable (≥90% viable; n = 2 field of views per 
condition) for the duration of the experiment. Gelatinase zymography confirmed the expected 
gelatinase production by HT-1080 and MCF-7 cells [5,47,48]. HT-1080 cells produced both MMP-2 
(68 kDa and 72 kDa) and MMP-9 (92 kDa) and MCF-7 cells did not produce detectable amounts of 
the gelatinases (Figure 6C,D). Taken together, the observed intracellular fluorescence within HT-1080 
cells was mediated by specific MMP-2 and MMP-9 hydrolysis of 5FAM6-THP and was neither due to 
non-specific processes nor due to a loss of cell viability. 
The attenuation of the fluorescence signal in HT-1080 cells incubated with the gelatinase inhibitor 
SB-3CT was an indication that the observed fluorescence was, in part, due to gelatinase activity. The 
levels of SB3-CT were 72-fold the Ki value for MMP-2 (Ki = 0.0139 μM [49]) which ensures 
approximately 99% occupancy of MMP-2 at equilibrium. The inability to completely inhibit apparent 
proteolysis of 5FAM6-THP may have been due to non-equilibrium conditions resulting in uninhibited 
gelatinase activity or due to fluorescence from incomplete quenching of the 5FAM fluorescent dyes 
within 5FAM6-THP. This hypothesis is supported by the low levels of fluorescence observed in  
SB-3CT treated HT-1080 cells and in the gelatinase negative MCF-7 cells. The gelatinase mediated 
intracellular fluorescence in HT-1080 cells is of particular interest because it could influence net 
tumor-associated fluorescence in vivo. 
Gelatinase mediated proteolysis of 5FAM6-THP resulted in a loss of the triple-helical conformation 
and a subsequent diffusion of the peptide fragments with concomitant increase in fluorescence as the 
proximity of the fluorophores decreased [50]. The single-stranded proteolytic fragments were then 
internalized into the HT-1080 cells, and in some cases, were intra-vesiculary located. MCF-7 cells, in 
contrast, did not exhibit observable intracellular fluorescence. Without gelatinase activity,  
5FAM6-THP remained intact, with the 5FAM molecules quenched and without proteolytic fragments 
for cell internalization. While a complete study of the mechanism of internalization was beyond the 
scope of this investigation, it is useful to note that functionally active MMP-2 is non-covalently bound 
to the surface of numerous cancer cells. MMPs, including MMP-2, bind other ubiquitous receptors, 
such as αvβ3 integrin, which is generally ubiquitously expressed, albeit at various levels, in 
xenografted tumors and in human tumor tissue [51–54], and the cell surface proteoglycan CD44, 
which is overexpressed on many tumors and cancer stem cells. An example of these interactions is the 
interaction of the CD44 splice variant CD44v3,8-10 in metastatic breast cancer cells with active MMP-9 
within invadopodia structures [55]. The interaction of CD44v3-10 and MMP-9 is also found in prostate 
cancer cells [56]. Association of CD44 with active MMP-9 in metastatic breast cancer and melanoma 
cells leads to the activation of TGF-β and the promotion of the degradation of type IV collagen with 
subsequent cell invasion [57,58]. The close association of the gelatinases with CD44 and αvβ3 may 
explain the strong intracellular signal. Mechanisms of internalization of the proteolyzed fragments may 
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include passive egress of the proteolytic fragments into the cytosol as well as pinocytosis or receptor 
mediated endocytosis (in the case of αvβ3) into endosomes.  
Figure 6. (A) Confocal fluorescence microscopy showing the hydrolysis of 5FAM6-THP 
by HT-1080 human fibrosarcoma cells. HT-1080 or MCF-7 human breast cancer cells 
were treated with 5FAM6-THP (1 µM) for 1 h. For inhibition studies, cells were pre-
incubated with SB-3CT (1 µM) for 30’ prior to 5FAM6-THP incubation. Two image fields 
are shown per condition. The first column represents the fluorescence from 5FAM-THP. 
The second column represents the corresponding brightfield image. Overlays of the 
fluorescence and brightfield images are shown in the third column (taken using the  
10× objective) with higher magnification images in the fourth column (taken using the  
60× objective) to show cell internalization of 5FAM-THP. Scale bars are indicated in the 
first image of each column. (B) Mean cell associated fluorescence quantified with FV1000 
software. (n = 10 cells, “I” denotes SB-3CT, “1080” denotes HT-1080 cells). P-values 
were determined using a Student’s two-tailed t-test; “*” denotes p < 0.05). (C) Zymogram 
depicting gelatinase content of cell-associated media with varying total protein loading. 
Varying levels of total protein from the conditioned media (0.41 µg, 2.07 µg, and 4.14 µg) 
were loaded into each well of a 10% Zymogram Gel with gelatin. Proteins were 
electrophoresed at 100 V for 90 min and after electrophoresis, the proteins were renatured 
in 2.5% Triton X-100. The gel was then incubated overnight at 37 °C in development 
solution and stained with Coomassie Blue. (D) Zymograms of MMP-2 and MMP-9 
standards that were used in enzymology experiments and in Figure 6C to verify gelatinase 
content of cell-associated media. 
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Figure 6. Cont. 
 
 
3. Experimental 
3.1. Chemicals  
All standard peptide synthesis chemicals were analytical reagent grade or better and purchased  
from EMD Biosciences (San Diego, CA, USA) or Fisher Scientific (Pittsburgh, PA, USA).  
9-Fluorenylmethoxycarbonyl-amino acid derivatives were obtained from EMD Biosciences. Amino 
acids are of the L-configuration (except for Gly). 5FAM (5-carboxyfluorescein, single isomer) was 
from Invitrogen (Carslbad, CA, USA). The MMP-2 and MMP-9 inhibitor, SB-3CT, was from Enzo 
Life Sciences (Plymouth Meeting, PA, USA).  
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3.2. Solid Phase Peptide Synthesis  
The THPs were synthesized as previously described [59]. Either one or two 5FAMs per  
single-stranded peptide were conjugated to the peptides depending on the choices of the protecting 
groups on one of ε-Lys groups. The generic synthetic route is shown in Figure 1. After removal of the 
Dde protecting groups (2% hydrazine, DMF), rinsing (3 × 5 mL DMF, 10% aqueous DMF,  
CH2Cl2, CH3OH), and drying (in vacuo), 5FAM was conjugated to the ε-amino groups of Lys 
(resin:5FAM:HOBt:DIC:DMAP = 1:X:X:2X:X, X = 3 or 6) in DMF. After reaction (16 h), the mixture 
was filtered, and rinsed (3 × 5 mL DMF, CH2Cl2, CH3OH). The Kaiser test was negative indicating 
complete coupling of 5FAM. The peptide was cleaved from the resin (water-TFA 1:19, 3 h), diluted 
with water, and lyophilized. The crude mixture was re-dissolved (0.1% acetic acid) and purified by 
size exclusion gel chromatography (G-25). Substitution levels were determined by absorption (480 nm) 
utilizing the ninhydrin method and bovine insulin as a standard [41] and molecular weight was 
confirmed by ESI-TOF-MS. 
3.3. THP Quenching  
To determine whether conjugation of 5FAM to the peptide changed the emission spectra, the 
fluorescence of 5FAM-THPs were compared to that of 5FAM free in solution. The concentrations of 
both 5FAM and 5FAM6-THP were adjusted to 2 µM (±0.05 µM, PBS). Emission spectra  
(λem = 400 to 600 nm, λex = 480) were obtained. To determine the amount of quenching, the 
fluorescence of unhydrolyzed 5FAM-THPs (fintact) (5FAM3-THP and 5FAM6-THP) were compared 
with the fluorescence of completely hydrolyzed 5FAM-THPs (fhydrolyzed), utilizing [(fhydrolyzed − 
fintact)/fhydrolyzed] × 100 = percent quenched. Three concentrations of 5FAM-THPs (0.5 µM, 0.15 µM, 
and 0.07 µM, n = 3 per sample) were digested with MMP-9 (14 nM) until fluorescence reached a 
plateau with no further increases (2.5 h). 
3.4. Calculation of Förster Distance  
To calculate the Förster distance, a model of a collagenous generic THP was used. This model, 
consisting of repeating GAA (alanine residues were substituted in place of proline and hydroxyproline 
for simplification) triplets of 30 amino acids ([(GAA)10]3) was composed from the high resolution 
crystal structures of several THPs in order to predict peptide backbone and α-carbon locations within 
the helix [38]. A PDB format file (GAA_THim.pdb) with the coordinates of a model THP was 
imported in to Chemdraw3d Pro 9.0 to make the measurements. Utilizing the software’s measurement 
function, the distances between α-carbons of A18 and A27 of one chain of the THP were determined. 
These two amino acids correspond to the pair of lysine residues (that were conjugated to the dye) that 
flank the hydrolysis site. The distance between the α-carbon of A18 in the first chain and that of the  
α-carbons of the other two alanines (A27) from the other two chains were also measured.  
3.5. Enzyme Assays  
MMP-2 (72 kDa) and MMP-9 (94 kDa) for the enzyme assays were purchased from Enzo Life 
Sciences. 72 kDa MMP-2 (rat) and 94 kDa MMP-9 (rat) were from R & D Biosystems (Minneapolis, 
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MN, USA). The 72 kDa MMP-2 (or MMP-2) was activated using 4-aminophenylmercuric acetate 
(APMA). An APMA solution was made at 10 mM (3.5 mg/mL) in assay buffer (50 mM tricine pH 7.4, 
50 mM NaCl, 10 mM CaCl2, 0.05% Brij-35) and diluted to 2 mM prior to addition to the proenzyme 
solution. APMA (2 mM) was added to the 72 kDa MMP-2 solution in equal parts by volume for a final 
solution of 1 mM. This solution was allowed to sit for 1 h at 37 °C before dilution in assay buffer. The 
94 kDa MMP-9 (or MMP-9) was activated by the addition of TPCK-trypsin (0.50 mg/mL) in 20 µL of 
activation buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 5 mM CaCl2, 0.02% Brij-35). This solution was 
allowed to sit at 37 °C for 20 min, after which 2 µL of aprotinin (1.0 mg/mL) was added. The resulting 
solution was brought up to a volume of 522 µL. 
Enzyme kinetics were carried out using activated 72 kDa MMP-2 and 94 kDa MMP-9 at nominal 
concentrations of 10 or 20 nM. The amount of active enzyme (Et) was taken from published values of 
the percent active enzyme generated under identical conditions (70%, MMP-2, 100% MMP-9), or the 
values provided by manufacturer [60,61]. Reactions were performed in triplicate in 96-well microtiter 
plates in a total volume of 50 or 200 µL. Data was collected using a Synergy HT microplate reader 
(Bio-Tek, Winooski, VT, USA). The KM values of 5FAM-THP were determined by incubating the 
substrate (1 to 100 µM) with activated 72 kDa MMP-2 and 94 kDa MMP-9 in assay buffer. The 
fluorescence released by enzyme-mediated hydrolysis was measured at multiple time points on a 
microtiter plate reader. Initial velocities were obtained from plots of fluorescence with respect to time 
using only the linear portion of the data. Relative fluorescence units were converted from known 
concentrations of 5FAM in assay buffer. KM values were determined by non-linear regression and error 
values are expressed as the 95% confidence interval (Graphpad Prism, version 5.1, San Diego, CA, 
USA). kcat was determined from Et and KM. The kinetics data are presented as Lineweaver-Burke plots. 
3.6. Circular Dichroism Spectroscopy and Melting Curves 
Circular dichroism spectra were collected over a range of λ = 190–300 nm on a JASCO J-815 
instrument (Tokyo, Japan) using a 1 mm path length quartz cell at 10 °C. Temperature control was 
maintained with a Peltier equipped temperature control unit.  
3.7. MMP Zymography  
The cell growth media of HT-1080 and MCF-7 cells (DEME, 10% fetal calf serum, 100 units/mL 
penicillin) was replaced with serum free medium to generate conditioned media 24 h prior to 
zymography. The protein content of the conditioned media from each cell line was analyzed and 
subjected to zymographic analysis. Varying levels of total protein from the conditioned media (0.41 µg, 
2.07 µg, and 4.14 µg) were loaded into each well of a 10% Zymogram Gel with gelatin (BioRad, 
Hercules, CA, USA). Proteins were electrophoresed at 100 V for 90 min in Tris-glycine buffer 
containing 0.1% SDS. After electrophoresis, the proteins were renatured in 2.5% Triton X-100 after 
which the gel was incubated overnight at 37 °C in development solution (50 mM Tris, 200 mM NaCl, 
5 mM CaCl2, 0.02% Brij-35). The gel was stained for 1 h at room temperature in 40% methanol, 10% 
acetic acid, 0.05% Coomassie Blue R-250, followed by destaining in 40% methanol, 10% acetic acid. 
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3.8. Confocal Microscopy 
Cells were grown on Lab-Tek slides in DMEM, 10% fetal calf serum, 100 units/mL penicillin. The 
medium was replaced and cells were incubated with 5FAM6-THP (1 μM, 1 h). For the inhibitor 
studies, cells were pre-treated with a MMP-2 and MMP-9 inhibitor (SB-3CT, 1 μM, 30 min) after 
which 5FAM6-THP (1 μM, 1 h) was added to the wells so that the inhibitor was present for the entire 
incubation. The concentration of 5FAM6-THP was chosen to ensure significant saturation of the 
gelatinases to produce a detectable signal that would rise above level of autofluorescence in a 
reasonable amount of time before cell viability was lost. After rinsing, a cell viability assay was 
performed with ethidium homodimer-1 (EthD-1; 1 μM, 1 h). Then the slides were rinsed with PBS, 
mounted, and coverslipped. They were visualized using an Olympus FV1000 microscope (Center 
Valley, PA, USA) using a 20X/0.95 W water immersion objective. Fluorescence emission of  
5FAM6-THPwas detected from 490 to 550 nm using a 488 nm laser at 5% power. Images of each 
group of slides were acquired with the same microscope settings during a single imaging session, 
allowing for quantitative analysis of cellular fluorescence. Relative fluorescence of the cells was 
quantified with FV1000 software in terms of fluorescence per unit area. Relative fluorescence of ten 
cells of each image was determined and the results averaged (with standard deviation; n = 10). The 
results were analyzed with an unpaired, two-tailed t-test (GraphPad Prism version 4.00 Software). 
4. Conclusions  
The goal of the study was to synthesize and evaluate homotrimeric triple-helical peptides composed 
of single-stranded peptides bearing 5FAM fluorescent dyes flanking the hydrolysis site for their ability 
to detect gelatinase activity in cell culture. These 5FAM-THPs were characterized for the ability of the 
single-stranded peptides, bearing one or two fluorescent dyes, to self-assemble into a triple-helix and 
be efficiently hydrolyzed by the gelatinases. The 5FAM fluorophore was added while the single 
stranded-peptide was resin bound and the addition of DMAP greatly increased the coupling efficiency. 
After release from the resin and purification, mass spectrometry data and the strong positive and 
negative molar ellipticities of 5FAM-THPs indicated that the single-stranded peptides bearing either 
one of two 5FAMs had indeed self-assembled into a triple-helix. While the level of quenching, up to 
50%, was lower than that of other proteolytic sensors that have been used in vivo in the past, it should 
be noted that minimum quenching levels for in vivo fluorescence imaging of proteolytic activity with 
quenched probes are not known. Additionally, the kinetics of enzymatic hydrolysis of 5FAM-THPs 
(MMP-2 hydrolysis of 5FAM6-THP kcat/kM was 1.5 × 104 M−1 s−1) were well within the range of 
kinetic parameters of enzymatic probes that have successfully visualized proteolytic activity in vivo. 
Finally, the gelatinases secreted from HT-1090 human cancer cells were capable of proteolyzing 
5FAM6-THP, which was confirmed by an increase in fluorescence signal resulting from THP 
hydrolysis and dequenching of 5FAM fluorophores. This proteolysis was blocked by a gelatinase 
inhibitor. Fusrthermore, 5FAM6-THP hydrolysis did not occur in gelatinase negative MCF-7 cells, 
indicating that 5FAM-THP proteolysis was gelatinase specific and did not result from THP 
denaturation or non-specific proteolysis. Taken together, these data support the use of THPs labeled 
with fluorophores for in vivo imaging of gelatinase activity.  
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